Report on the SA Hypertension Congress (7-9 March 2003): successful combination of CME and new research.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003131:Combined Modality Therapy; D004032:Diet; D004502:Education, Medical, Continuing / Q000592:standards / Q000639:trends*; D005544:Forecasting; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D012106:Research / Q000592:standards / Q000639:trends*; D018570:Risk Assessment; D012955:Societies, Medical; D013019:South Africa
D000319:Adrenergic beta-Antagonists; D000960:Hypolipidemic Agents